Wainua is only available at specialty pharmacies. They will mail your auto-injector and sharps container to you. If you need help paying for Wainua, the drugmaker may be able to assist you.

Wainua (eplontersen) is a brand-name injection that’s prescribed for nerve damage related to amyloidosis (buildup of amyloid protein). As with other drugs, Wainua can cause side effects, such as ...

WAINUA WAINUA (eplontersen) is a ligand-conjugated antisense oligonucleotide (LICA medicine designed to reduce the production of transthyretin, or TTR protein. 2,7 WAINUA has been approved in the ...

A program called Astra Zeneca Access 360 is available for Wainua. For more information and to find out whether you’re eligible for this program, you can call 844-275-2360 or visit the program ...

WAINUA has been approved in the U.S. for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults (also referred to as ATTRv-PN).

Learn about uses, side effects, dosage, and more for Wainua. It's a prescription drug used to treat nerve problems in adults with a certain genetic condition.

Wainua™ (eplontersen) granted regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis. News release. Ionis Pharmaceuticals.

Analyst sees potential for Wainua sales in ATTR-PN alone, which will be a significant value driver. Ionis remains William Blair's top pick for 2024, and the analyst reiterates the Outperform ...

U.S. INDICATION for WAINUA™ (eplontersen) WAINUA injection for subcutaneous use 45 mg is indicated for treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved Ionis and AstraZeneca's WAINUA™ (eplontersen) for the treatment of the ...